Over the past several decades, obesity has grown into a global pandemic.
With nearly 40 percent of adults worldwide classified as overweight or obese, obesity is to blame for dozens of debilitating diseases, increasing costs of healthcare, growing mortality rates and devastating indirect effects that impact the global economy. Fortunately, obesity is largely preventable and treatable.
Why truMED?
Prof. Le Roux’s experience with truME and truRO and their potential to revolutionize patient care before, during, and after bariatric weight loss surgery.
“ We think that truME can be part of the solution to drive long term health gains for our patients after bariatric surgery.“
Prof. Carel Le Roux, Obesity physician and world-renowned metabolic medicine expert
Marketplace Growth
COVID-19 has skyrocketed the need for and use of telehealth and digital health solutions.
Founded in Science
Research shows that long-term bariatric success requires ongoing intervention and support.
State-of-the-Art Technology
The truMED solutions leverage specialized software that supports obesity management and bariatric care in new ways
Management
truMED is led by a team of professionals with decades of experience in the medical device industry with the support of a global team of medical and technology experts.
Kelly Ladner
CEO
Evan Wooldridge
CRO
Richard Creagh
European President
Darla Young
CFO
Clinical
Michael L. Green, Jr.
M.D., F.A.C.S., F.A.S.M.B.S.
Nathaniel Lytle
M.D., F.A.C.S.
John Conneely
BSc., M Ch., F.R.C.S.I.
Parham Mora
M.D., F.A.C.S.
Advisory
Michael Gorton
Founder, Teladoc
Prof. Carel Le Roux
Chairman, SOPHIA
Ian Gargan
Founder, Imagine Health; CEO, PHIN